GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Ardent Health Partners Inc (NYSE:ARDT) » Definitions » Peter Lynch Fair Value

ARDT (Ardent Health Partners) Peter Lynch Fair Value : $9.12 (As of Nov. 28, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Ardent Health Partners Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Here, as of today, Ardent Health Partners's PEG is 1. Ardent Health Partners's 5-Year TTM EBITDA Growth Rate is 24.78. Ardent Health Partners's EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was $0.37. Therefore, the Peter Lynch Fair Value for today is $9.12.

As of today (2024-11-28), Ardent Health Partners's share price is $15.94. Ardent Health Partners's Peter Lynch fair value is $9.12. Therefore, Ardent Health Partners's Price to Peter Lynch Fair Value Ratio for today is 1.75.


The historical rank and industry rank for Ardent Health Partners's Peter Lynch Fair Value or its related term are showing as below:

ARDT' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0   Med: 0   Max: 1.75
Current: 1.75


During the past 6 years, the highest Price to Peter Lynch Fair Value Ratio of Ardent Health Partners was 1.75. The lowest was 0.00. And the median was 0.00.


ARDT's Price-to-Peter-Lynch-Fair-Value is ranked worse than
58.73% of 189 companies
in the Healthcare Providers & Services industry
Industry Median: 1.46 vs ARDT: 1.75

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


Ardent Health Partners Peter Lynch Fair Value Historical Data

The historical data trend for Ardent Health Partners's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ardent Health Partners Peter Lynch Fair Value Chart

Ardent Health Partners Annual Data
Trend Dec16 Dec17 Dec18 Dec21 Dec22 Dec23
Peter Lynch Fair Value
Get a 7-Day Free Trial - - - - 9.12

Ardent Health Partners Quarterly Data
Dec16 Sep17 Dec17 Sep18 Dec18 Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 9.12 - - -

Competitive Comparison of Ardent Health Partners's Peter Lynch Fair Value

For the Medical Care Facilities subindustry, Ardent Health Partners's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ardent Health Partners's Price-to-Peter-Lynch-Fair-Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Ardent Health Partners's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where Ardent Health Partners's Price-to-Peter-Lynch-Fair-Value falls into.



Ardent Health Partners Peter Lynch Fair Value Calculation

Ardent Health Partners's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* 24.78 *0.368
=9.12

Ardent Health Partners's EPS without NRI for the trailing twelve months (TTM) uses the latest annual data, which was $0.37.

* Note that for companies that do not have enough quarterly data to calculate the 5-Year TTM EBITDA Growth Rate, we use the annual data for the calculation.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


Ardent Health Partners  (NYSE:ARDT) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 24.78 instead of 15 in this case.

Ardent Health Partners's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=15.94/9.12
=1.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ardent Health Partners Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of Ardent Health Partners's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Ardent Health Partners Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
340 Seven Springs Way, Suite 100, Brentwood, TN, USA, 37027
Ardent Health Partners Inc is an operator of hospitals and a provider of healthcare services in the United States. It provide both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. The company has one reportable segment: healthcare services that provides healthcare services primarily through its ownership and operation of hospitals, certain of which provide related healthcare services through physician practices, outpatient centers, and post-acute facilities. Ardent has 30 acute care hospitals, more than 200 sites of care that operates across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas.